A novel endoimaging system for endoscopic 3D reconstruction in bladder cancer patients.

3D-reconstruction Bladder cancer artificial neural network bladder phantom model cystoscopy semantic image segmentation

Journal

Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy
ISSN: 1365-2931
Titre abrégé: Minim Invasive Ther Allied Technol
Pays: England
ID NLM: 9612996

Informations de publication

Date de publication:
Jan 2022
Historique:
pubmed: 4 6 2020
medline: 5 2 2022
entrez: 4 6 2020
Statut: ppublish

Résumé

The methods employed to document cystoscopic findings in bladder cancer patients lack accuracy and are subject to observer variability. We propose a novel endoimaging system and an online documentation platform to provide post-procedural 3D bladder reconstructions for improved diagnosis, management and follow-up. The RaVeNNA4pi consortium is comprised of five industrial partners, two university hospitals and two technical institutes. These are grouped into hardware, software and clinical partners according to their professional expertise. The envisaged endoimaging system consists of an innovative cystoscope that generates 3D bladder reconstructions allowing users to remotely access a cloud-based centralized database to visualize individualized 3D bladder models from previous cystoscopies archived in DICOM format. Preliminary investigations successfully tracked the endoscope's rotational and translational movements. The structure-from-motion pipeline was tested in a bladder phantom and satisfactorily demonstrated 3D reconstructions of the processing sequence. AI-based semantic image segmentation achieved a 0.67 dice-score-coefficient over all classes. An online-platform allows physicians and patients to digitally visualize endoscopic findings by navigating a 3D bladder model. Our work demonstrates the current developments of a novel endoimaging system equipped with the potential to generate 3D bladder reconstructions from cystoscopy videos and AI-assisted automated detection of bladder tumors.

Identifiants

pubmed: 32491933
doi: 10.1080/13645706.2020.1761833
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

34-41

Auteurs

Rodrigo Suarez-Ibarrola (R)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg, Germany.

Maximilian Kriegmair (M)

Department of Urology, University Hospital Mannheim, Mannheim, Germany.

Frank Waldbillig (F)

Department of Urology, University Hospital Mannheim, Mannheim, Germany.

Britta Grüne (B)

Department of Urology, University Hospital Mannheim, Mannheim, Germany.

Misgana Negassi (M)

Fraunhofer Institute for Physical Measurement Techniques IPM, Freiburg, Germany.
Department of Sustainable Systems Engineering INATECH, University of Freiburg, Freiburg, Germany.

Ujwala Parupalli (U)

Fraunhofer Institute for Physical Measurement Techniques IPM, Freiburg, Germany.
Department of Sustainable Systems Engineering INATECH, University of Freiburg, Freiburg, Germany.

Annette Schmitt (A)

Fraunhofer Institute for Physical Measurement Techniques IPM, Freiburg, Germany.
Department of Sustainable Systems Engineering INATECH, University of Freiburg, Freiburg, Germany.

Alexander Reiterer (A)

Fraunhofer Institute for Physical Measurement Techniques IPM, Freiburg, Germany.
Department of Sustainable Systems Engineering INATECH, University of Freiburg, Freiburg, Germany.

Christoph Müller (C)

Hochschule Furtwangen University, Furtwangen, Germany.

Alexander Scheurer (A)

Hochschule Furtwangen University, Furtwangen, Germany.

Stefan Baur (S)

QIT Systeme GmbH & Co. KG, Mannheim, Germany.

Kirsten Klein (K)

KARL STORZ SE & Co. KG, Tuttlingen, Germany.

Johannes A Fallert (JA)

KARL STORZ SE & Co. KG, Tuttlingen, Germany.

Lars Mündermann (L)

KARL STORZ SE & Co. KG, Tuttlingen, Germany.

Jenshika Yoganathan (J)

KARL STORZ SE & Co. KG, Tuttlingen, Germany.

Marco Probst (M)

DORNER GmbH & Co. KG, Müllheim, Germany.

Patrick Ihle (P)

DORNER GmbH & Co. KG, Müllheim, Germany.

Neven Bobic (N)

Actuator Solutions, GmbH, Gunzenhausen, Germany.

Tobias Schumm (T)

Actuator Solutions, GmbH, Gunzenhausen, Germany.

Henning Rehn (H)

FISBA Photonics AG, Berlin, Germany.

Alexander Betke (A)

FISBA Photonics AG, Berlin, Germany.

Michael Graurock (M)

FISBA Photonics AG, Berlin, Germany.

Martin Forrer (M)

FISBA Photonics AG, Berlin, Germany.

Christian Gratzke (C)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg, Germany.

Arkadiusz Miernik (A)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg, Germany.

Simon Hein (S)

Department of Urology, Faculty of Medicine, University of Freiburg - Medical Centre, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH